Skip to main content

Headlines

Can Omega-3 Supplements Help Children With ADHD? A New Study Finds 1 Modest Benefit
posted:
by: Inc.
#channels:: #All, #Business, #Entrepreneur
ChatGPT and Other AI Tools Are Changing How We Learn. A Massive New Study Calls It ‘Knowledge Collapse’
posted:
by: Inc.
#channels:: #All, #Business, #Entrepreneur
Your Car Is Spying on You. A New Study Shows Just Who It’s Telling Your Secrets To.
posted:
by: Entrepreneur
#channels:: #All, #Business, #SmallBusiness, #Entrepreneur
Pfizer's Tilrekimig Delivers Significant Skin Clearance In Phase 2 Atopic Dermatitis Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Monte Rosa Set To Report MRT-8102 Phase 1 Data In Cardiovascular Risk Study Today; Stock Up
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Foundayo Demonstrates Cardiovascular Safety In Landmark Diabetes Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study 
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
Lilly's EBGLYSS Shows Rapid Skin Clearance And Symptom Relief In Phase 3b Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Lilly's Retatrutide Drives Significant Weight Loss And A1C Improvement In Phase 3 Diabetes Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Oncolytics Nears Interim Data Update From Randomized REO 033 Colorectal Cancer Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Mirum's Brelovitug Meets Phase 3 Goals In Chronic Hepatitis Delta Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
OSE Immunotherapeutics Highlights Pipeline Progress As Phase 3 Tedopi Study Advances
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Innovent Expands Phase 3 IBI363 Study To Non-Squamous Lung Cancer; Stock Down
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Mirum To Announce Topline Results From Phase 3 AZURE-1 Study For Brelovitug
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks